HIGHLIGHTS
- who: Shih-Han Ko from the (UNIVERSITY) have published the research: Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants, in the Journal: (JOURNAL)
- how: This mAb was used in the experiment because it displayed the most effective neutralizing activity.
- future: These antibodies may serve as starting points for the development of novel therapeutics to be used in the current and future pandemics.
SUMMARY
The BA.1 sublineage of Omicron harbors 28 altered amino_acid residues in the S1 subunit and 6 altered . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.